文献

J-GLOBAL ID：201502286505753771   整理番号：15A0584217

非Hodgkinリンパ腫由来のリツキシマブ関連進行性多巣性白質脳症:神経病理学的所見とメフロキン治療の結果

Rituximab-associated Progressive Multifocal Leukoencephalopathy Derived from Non-Hodgkin Lymphoma: Neuropathological Findings and Results of Mefloquine Treatment

著者 (12件)： SANO Yasuteru (Dep. of Neurology and Clinical Neuroscience, Yamaguchi Univ. Graduate School of Medicine, JPN) ,  NAKANO Yuta (Dep. of Neurology and Clinical Neuroscience, Yamaguchi Univ. Graduate School of Medicine, JPN) ,  OMOTO Masatoshi (Dep. of Neurology and Clinical Neuroscience, Yamaguchi Univ. Graduate School of Medicine, JPN) ,  TAKAO Masaki (Dep. of Neuropathology, the Brain Bank for Aging Res., Tokyo Metropolitan Geriatric Hospital, JPN) ,  IKEDA Eiji (Dep. of Pathology, Yamaguchi Univ. Graduate School of Medicine, JPN) ,  OGA Atsunori (Dep. of Pathology, Yamaguchi Univ. Graduate School of Medicine, JPN) ,  NAKAMICHI Kazuo (Dep. of Virology I, National Inst. of Infectious Disease, JPN) ,  SAIJO Masayuki (Dep. of Virology I, National Inst. of Infectious Disease, JPN) ,  MAOKA Takashi (Res. Inst. for Production Dev., JPN) ,  SANO Hironori (Dep. of Neurology and Clinical Neuroscience, Yamaguchi Univ. Graduate School of Medicine, JPN) ,  KAWAI Motoharu (Dep. of Neurology and Clinical Neuroscience, Yamaguchi Univ. Graduate School of Medicine, JPN) ,  KANDA Takashi (Dep. of Neurology and Clinical Neuroscience, Yamaguchi Univ. Graduate School of Medicine, JPN)
資料名： Internal Medicine (Web)  (Internal Medicine (Web))
巻： 54  号： 8  ページ： 965-970 (J-STAGE)  発行年： 2015年 
JST資料番号： U0033A  ISSN： 1349-7235  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 非Hodgkinリンパ腫(NHL)の66歳男性が,リツキシマ...

シソーラス用語： ヒト ,...
準シソーラス用語： リツキシマブ ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A0584217&from=J-GLOBAL&jstjournalNo=U0033A") }}

分類 (2件)： 神経系疾患の薬物療法  (GN05020Y) ,  感染症・寄生虫症の治療  (GD01030D)

物質索引 (1件)： メフロキン

引用文献 (21件)：

• 1. Aström KE, Mancall EL, Richardson EP Jr. Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 81: 93-111, 1995.
• 2. Carson KR, Focosi D, Major EO, et al. Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol 10: 816-824, 2009.
• 3. Carson KR, Evens AM, Richey EA, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 113: 4834-4840, 2009.
• 4. Brickelmaier M, Lugovskoy A, Kartikeyan R, et al. Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother 53: 1840-1849, 2009.
• 5. Schröder A, Lee DH, Hellwig K, Lukas C, Linker RA, Gold R. Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis. Arch Neurol 67: 1391-1394, 2010.

タイトルに関連する用語 (7件)： 非Hodgkinリンパ腫 ,  リツキシマブ ,  進行性多巣性白質脳症 ,  神経 ,  病理学的所見 ,  メフロキン ,  治療